Winner of the SunSafe Student Ambassador Program announced
11 December 2019
Belmont High School at Lake Macquarie has been announced winner of the 2019 SunSafe Student Ambassador Program video competition. Melanoma Institute Australia today attended the end of year assembly at Belmont High where they presented the award to students Brieanna Anderson, Alana Cross, Sophie Pilgrim and Amelia Velkouski and $1,000 in prize money for the school to use on sun safety initiatives.
The award is for the most powerful and engaging sun safety presentation given by student ambassadors to their peers at their schools, following their participation in MIA’s SunSafe Student Ambassador Program.
Six day-long sun safety and melanoma awareness sessions were run along the east coast of Australia in recent months. Of the 62 high schools which sent student representatives to participate, 44 submitted videos entries of their presentations delivered back at their schools. Muswellbrook High School in NSW was awarded 2nd place and Townsville Grammar School in QLD was awarded 3rd.
‘Our independent judging panel was blown away by the creativity and passion displayed in all the video entries,’ said Melanoma Institute Australia CEO Matthew Browne. ‘Belmont High’s presentation stood out due to its combination of humour, innovation and emotion to really engage students and generate behavioural change in terms of sun safety and melanoma prevention.’
The independent judging panel included Professor David Currow, Chief Cancer Officer of NSW; Associate Professors Matt Carlino and Robyn Saw who are both on Faculty at MIA; melanoma patients Craig Lawn, Natalie Fornasier and Jason Clare MP; and MIA major benefactor Kay Poche AO.
The Sun Safety Student Ambassador Program will return in 2020 and high schools can register their interest here: SunSafe Student Ambassador Program
Watch the winning video:
Australasian Melanoma Conference AMC2021
The 2021 Australasian Melanoma Conference (AMC2021) will held in Sydney, Australia.
Sharing our knowledge of melanoma on the global stage
As leaders in the field of melanoma, clinicians and researchers from MIA will be sharing their knowledge at the virtual 10th World Congress of Melanoma.
Melanoma patients and their families urged to speak up and put national spotlight on melanoma.
Melanoma patients and their carers are being urged to participate in a ground-breaking survey which will shape the future of melanoma treatment, research, support and funding in Australia.
An inspiring WA Melanoma Community Forum
There was a wonderful feeling of community support amongst the melanoma patients, families and friends at the WA Melanoma Community Form.
Family of 8-year-old with melanoma calls on all Australians to step up to help save lives
The Price family has decided to share their story to inspire Australians to support research into new melanoma treatments.
Rethinking skin surveillance for high-risk melanoma patients
New research has provided evidence in favour of a structured skin surveillance program for high-risk melanoma patients.
Australia's oldest melanoma survivor steps up to save lives on his 105th birthday
Melanoma research saved Bert's life at 101 and now he wants to give back.
Predicting disease spread in thin melanoma
A new MIA online risk calculator for clinicians can determine the likelihood of thin melanoma spreading.
Exploring our own clinical questions through MIA's new trials initiative
MIA has recently established a new division of our Clinical Trials Program which co-ordinates and manages investigator-led multi-centre trials.
Young researchers awarded Fellowships to pursue innovative treatments for melanoma
Two young researchers from MIA and The University of Sydney awarded Cancer Institute NSW fellowships.
Young researchers receive boost to develop innovative treatment for melanoma
Two young researchers from MIA and The University of Sydney awarded Cancer Institute NSW fellowships.
Launch of Melanoma March 2021
Aussies urged to leave their footprint on melanoma as efforts step up to save lives from the disease.
Olivia Vivian announced as MIA ambassador
Olivia is using her Ninja star power to shine a spotlight on melanoma prevention - in memory of her dad.
Melanoma breakthrough - neoadjuvant treatment saving lives.
Drug treatment before surgery, known as neoadjuvant therapy, is being hailed as one of the biggest breakthroughs in melanoma treatment since the advent of immunotherapy.
Melanoma breakthrough - neoadjuvant therapy saving lives.
Drug treatment before surgery, known as neoadjuvant therapy, is being hailed as one of the biggest breakthroughs in melanoma treatment since the advent of immunotherapy.
Are cancer patients on immunotherapy at a greater risk of severe COVID-19 infection?
New research, led by MIA, has revealed that cancer patients treated with immunotherapy are not at a higher risk of developing severe COVID-19 infection compared to other cancer patients.
Are cancer patients on immunotherapy at a greater risk of severe COVID-19 infection?
New research, led by MIA, has revealed that cancer patients treated with immunotherapy are not at a higher risk of developing severe COVID-19 infection compared to other cancer patients.
A message to all Australians from melanoma patient Stuart Taylor
Stuart has advanced melanoma which is not responding to treatment. He has shared his story on ABC's 7:30 in the hope that others can escape the same fate.
Olivia Vivian nominates MIA as Charity Partner on Channel 9's Celebrity Apprentice.
A Ninja Warrior legend and Olympic gymnast, Olivia knows first hand the devastating impact of melanoma.
It's 'Game On Mole' this summer!
All Australians are urged to join the fight against melanoma this summer.